Dr. Elan Ziv
Dr. Elan Ziv, MD, OBGYN, FPMRS, CEO & Medical Director
Dr. Ziv graduated from the Sackler School of Medicine at the Tel-Aviv University in Israel and received his MD degree in 1979. He spent 5 years’ service as a doctor in the Israeli Defense Forces, and then completed his residency in Obstetrics and Gynecology (OBGYN) at the Rabin Medical Center (campus Beilinson), from which he graduated in 1990. During that time he also had a fellowship in FPMRS (Urogynecology), as a clinical-research fellow at St Georges Hospital, in London, UK, under Prof Stuart Stanton.
Until 2014, Dr. Ziv served as the Director of Institute of Urogynecology at Assuta Medical Centers in Tel Aviv, Israel.
As a urogynecologist, Dr. Ziv has a long standing interest in the non-invasive treatments of urinary incontinence and of pelvic organ prolapse in women. He is an active participant and presenter in many international professional meetings, participated as a Principle Investigator in many clinical studies, and holds 19 patents with over 100 patent applications.
Following the invention of various vaginal devices, he founded ConTIPI Ltd in 2002 and ConTIPI Medical Ltd in 2014. The company’s’ first flagship product – the Impressa Device for Stress Urinary Incontinence in women, was sold to Kimberly-Clark Worldwide Inc. and is now on the shelves under the name Poise Impressa. Second leading invention, the ProVate Device for Pelvic Organ Prolapse in women, is ready for the market and is now under regulatory consideration.